NCT06564805Status unknown
Clinical Trial on the Efficacy of Intralesional Triamcinolone Versus Candida Albicans Antigen in Treating Alopecia Areata
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Universidad Autonoma de Nuevo Leon
- Participants (registry)
- 30
- Start
- August 2024
- Primary completion
- July 2025
- Study completion
- December 2025
- Last registry update
- August 2024
- Countries
- Mexico
Conditions studied: Alopecia Areata
Interventions: Candida Albicans Antigen Injection
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.